Assessment of the New Automated Vitrification System "GAVI" for Early

Status Completed

Clinical Trial Summary

The meta-analysis comparing the cryopreservation of human embryos by vitrification or slow-freezing suggested that more well design studies as randomized trials are necessary to identify the most successful method for cryopreservation. The efficacy of the vitrification with the GAVI system will be compared with the conventional slow freezing method through a randomized control trial. Couples in IVF attempt will be randomized at the day of embryo cryopreservation by the biologist. Supernumerary frozen embryos will be thawed and transferred in utero in case of failure of the "fresh" embryo transfer. The outcomes of the thawing and frozen/thawed embryo transfer will be assessed. In the two groups, the patients will benefit of the standard IVF procedures applied in the Assisted Reproductive Technologies (ART) center of Toulouse.

Clinical Trial Description

The last decade has seen a development of a new cryopreservation technique called vitrification. Despite a lack of randomized control trials comparing slow-freezing and vitrification, vitrification seems to show better recovery rates and pregnancy outcomes. However vitrification is a manual, labour-intensive and highly skilled procedure, results can vary between embryologists and clinics. The GAVI system, an automation instrument with a novel closed system device has been developed. The present study would like to assess the outcomes for embryos automatically vitrification processed with the GAVI system compared with those processed with conventional reference technique of slow freezing. The meta-analysis comparing the cryopreservation of human embryos by vitrification or slow-freezing suggested that more well design studies as randomized trials are necessary to identify the most successful method for cryopreservation. The efficacy of the vitrification with the GAVI system will be compared with the conventional slow freezing method through a randomized control trial. Couples in IVF attempt will be randomized at the day of embryo cryopreservation by the biologist. Supernumerary frozen embryos will be thawed and transferred in utero in case of failure of the "fresh" embryo transfer. The outcomes of the thawing and frozen/thawed embryo transfer will be assessed. In the two groups, the patients will benefit of the standard IVF procedures applied in the Assisted Reproductive Technologies center of Toulouse. ;

Study Design

Related Conditions & MeSH terms

Fertility Disorders

Clinical Trial Details

NCT number	NCT03478592
Study type	Interventional
Source	University Hospital, Toulouse
Contact
Status	Completed
Phase	N/A
Start date	January 19, 2018
Completion date	February 3, 2021

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05634850` - Evaluating the Usability of the Product Kinder System Trial, Home Based Hormone for In-Vitro Fertilization (IVF) Monitoring System.
Completed	`NCT03803228` - Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders	Phase 3
Active, not recruiting	`NCT06053827` - Natural Frozen Embryo Transfer (FET) vs Substituted Frozen Embryo Transfer (FET)
Recruiting	`NCT03480412` - Second Step Protocol in Poor Ovarian Responder (POR)
Not yet recruiting	`NCT04606082` - Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI	N/A
Not yet recruiting	`NCT04604054` - The Effect of Granulocyte Colony Stimulating Factor Versus Human Chorionic Gonadotropin in Females With a History of RIF	N/A
Not yet recruiting	`NCT04589793` - COaching Lifestyle Intervention for FErtility	N/A
Completed	`NCT06441409` - Serum Ferritin Levels and Metabolic Dysfunction Associated Steatotic Liver Disease	N/A
Completed	`NCT03846544` - Double Pick up in Poor Prognosis Women	Phase 4
Completed	`NCT04141436` - Hypnofertility for Women Undergoing In Vitro Fertilization (HWUIVF)	N/A
Recruiting	`NCT05271981` - Fertility After Uterine Artery Embolization
Completed	`NCT03161873` - Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
Completed	`NCT03007043` - Genetic Variation in Gonadotropin and Gonadotropin Receptor Genes and Suboptimal Response
Completed	`NCT04133402` - Fertility After Intrauterine Tamponing Balloon: Where Are we
Active, not recruiting	`NCT06128395` - ASA 81 mg vs 162 mg During Frozen Embryo Transfer (FET)
Recruiting	`NCT05807256` - Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
Completed	`NCT03908697` - Quantum Natural Family Planning Pilot	N/A
Completed	`NCT04908774` - Effects of a Fasting Mimicking Diet on Sperm Quality	N/A
Recruiting	`NCT05205733` - Expanding Fertility Care to Poor and Low Resourced Settings Study	N/A
Active, not recruiting	`NCT03085212` - Strategies for Pregnancy Achievement	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Assessment of the New Automated Vitrification System "GAVI" for Early Cleaved Embryos Cryopreservation — GAVI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms